Your session is about to expire
← Back to Search
Scar Treatments for Post-Cesarean Section Pain
N/A
Waitlist Available
Research Sponsored by Jennifer Loomis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Female DoD beneficiaries age 18 years or older
3 months or greater postpartum with abdominal and/or back pain starting after low transverse Cesarean section scar.
Must not have
Vertical incision or emergent Cesarean section
Prior Scar Deactivation with Surface Release Technique for cesarean section scar within the last 12 weeks.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time 0, 4 weeks, 8 weeks, 16 weeks, 20 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is comparing two methods to reduce post-surgical pain related to a Cesarean section. One method is scar infiltration with Lidocaine and the other is scar deactivation with acupuncture.
Who is the study for?
This trial is for female DoD beneficiaries, 18 or older, who are experiencing abdominal/back pain starting after a low transverse Cesarean section and are at least 3 months postpartum. They must be able to receive care at specific military bases and not have had certain scar treatments recently.
What is being tested?
The study compares three approaches for chronic pain after Cesarean sections: injecting Lidocaine into the scar, using an acupuncture-like technique called Scar Deactivation Surface Release, and standard physical therapy. It aims to find out which method best reduces pain.
What are the potential side effects?
Lidocaine injections might cause temporary discomfort, bruising or infection at the injection site. The acupuncture-like technique could result in minor bleeding or soreness. Physical therapy may lead to muscle soreness.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a female over 18 and a beneficiary of the Department of Defense.
Select...
I am over 3 months postpartum and started having abdominal/back pain after a C-section.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I had a C-section with a vertical cut or it was an emergency.
Select...
I had a procedure to treat my cesarean section scar within the last 3 months.
Select...
I have an infection around a scar.
Select...
I have had surgery to correct a Cesarean section scar.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ time 0, 4 weeks, 8 weeks, 16 weeks, 20 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time 0, 4 weeks, 8 weeks, 16 weeks, 20 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Defense and Veterans Pain Rating Scale (DVPRS) between each time frame
Change in Patient and Observer Scar Assessment Scale (POSAS) between each time frame
Secondary study objectives
Single question asking if subjects' expectations were met? -- Binary yes/no
Single question asking subjects' change in pain severity reported as a percentile (10%, 20%, ...)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Scar Infiltration with 0.25-1% LidocaineExperimental Treatment1 Intervention
Will consist of calculation of 3 mg/kg dose of 0.5-1% Lidocaine and a dermal followed by subcutaneous injection using 1.5 inch 25 G needle and syringe appropriate for volume based on calculated dose.
Group II: Scar Deactivation Surface ReleaseExperimental Treatment1 Intervention
Alternating placement of Spring Ten (0.30x40 mm) acupuncture needles to surround scar left in place for a treatment duration of 20 minutes. Needles will be placed at intervals of 1cm to 1.5 cm and will surround the scar with a maximum of 20 needles per treatment.
Group III: Physical TherapyExperimental Treatment1 Intervention
Will be a referral to physical therapy specifying McKenzie protocol treatment for the presenting complaint. The McKenzie protocol is a form of standard of care physical therapy in which the physical therapist tries to find a cause and effect relationship between the positions the patient usually assumes while sitting, standing, or moving, and the location of pain because of those positions or activities. The therapeutic approach requires a patient to move through a series of activities and test movement to gauge the patient's pain response. The approach then uses that information to develop an exercise program designed to centralize or alleviate the pain.
Find a Location
Who is running the clinical trial?
Jennifer LoomisLead Sponsor
Mike O'Callaghan Military HospitalFED
32 Previous Clinical Trials
73,088 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I had a C-section with a vertical cut or it was an emergency.I completed a 12-week break after having Scar Deactivation for my cesarean section scar.I had a procedure to treat my cesarean section scar within the last 3 months.You have had a cesarean section with lidocaine injected into the scar.I have an infection around a scar.I am over 3 months postpartum and started having abdominal/back pain after a C-section.I have had surgery to correct a Cesarean section scar.I am a female over 18 and a beneficiary of the Department of Defense.
Research Study Groups:
This trial has the following groups:- Group 1: Scar Deactivation Surface Release
- Group 2: Scar Infiltration with 0.25-1% Lidocaine
- Group 3: Physical Therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger